









市場行情
/
股票
/
nasdaq-cdna
/

CareDx Inc

CDNA

12.780USD

+0.560+4.58%

交易中（美東）報價延遲15分鐘

708.81M總市值

12.04本益比TTM



CareDx Inc

12.780

+0.560+4.58%

概覽公司財務

CareDx, Inc. 是一家精準醫療解決方案公司。該公司專注於發現、開發和商業化針對移植患者和護理人員的臨牀差異化診斷解決方案。該公司在移植前後的患者旅程中提供檢測服務、產品以及患者和數字解決方案，併爲移植患者提供基於基因組學的信息。其商業化的檢測服務包括 AlloSure Kidney（一種用於腎移植患者的供體來源的無細胞 DNA (dd-cfDNA) 解決方案）；AlloMap Heart（一種用於心臟移植患者的基因表達解決方案）；AlloSure Heart（一種用於心臟移植患者的 dd-cfDNA 解決方案）和 AlloSure Lung（一種用於肺移植患者的 dd-cfDNA 解決方案）。該公司的產品組合包括 AlloSeq Tx、QTYPE、Olerup SSP、AlloSeq HCT 和 AlloSeq cfDNA。它爲各種移植接受者開發並提供診斷監測檢測服務。

公司簡介

公司代碼CDNA

公司名稱CareDx Inc

上市日期Jul 17, 2014

CEOMr. John W. Hanna

員工數量644

證券類型Ordinary Share

年結日Jul 17

公司地址8000 Marina Blvd

城市BRISBANE

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編94005

電話14152872300

網址https://www.caredx.com/

公司代碼CDNA

上市日期Jul 17, 2014

CEOMr. John W. Hanna

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Mr. Michael D. Goldberg

Independent Chairman of the Board

143.65K

+0.86%

Jessica Meng

Chief Commercial Officer

114.33K

+117.46%

Mr. Abhishek Jain

Chief Financial Officer

110.14K

-8.07%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Ms. Christine M. Cournoyer

Independent Director

38.58K

+45.71%

Mr. Jeffrey Adam Novack

General Counsel, Secretary

30.76K

-0.89%

Caroline Corner

Investor Relations

Ms. Jennifer Foley

Chief Product Officer

名稱

名稱/職務

職務

持股

持股變動

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Mr. Michael D. Goldberg

Independent Chairman of the Board

143.65K

+0.86%

Jessica Meng

Chief Commercial Officer

114.33K

+117.46%

Mr. Abhishek Jain

Chief Financial Officer

110.14K

-8.07%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

收入明細

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Testing Service revenue

61.92M

0.00%

Digital and other revenue

11.95M

0.00%

Product revenue

10.81M

0.00%

地區USD

名稱

營收

佔比

United States

79.86M

0.00%

Rest of the world

4.82M

0.00%

業務

地區

業務USD

名稱

營收

佔比

Testing Service revenue

61.92M

0.00%

Digital and other revenue

11.95M

0.00%

Product revenue

10.81M

0.00%

股東統計

更新時間: 5月17日週六

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

8.66%

BlackRock Institutional Trust Company, N.A.

7.56%

State Street Global Advisors (US)

4.46%

Baron Capital Management, Inc.

3.93%

Gagnon Securities LLC

3.83%

Other

71.55%

持股股東

佔比

The Vanguard Group, Inc.

8.66%

BlackRock Institutional Trust Company, N.A.

7.56%

State Street Global Advisors (US)

4.46%

Baron Capital Management, Inc.

3.93%

Gagnon Securities LLC

3.83%

Other

71.55%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

44.53%

Investment Advisor

41.96%

Hedge Fund

10.10%

Individual Investor

3.41%

Research Firm

2.92%

Pension Fund

0.57%

Bank and Trust

0.32%

Family Office

0.04%

Venture Capital

0.04%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

455

56.93M

102.27%

-3.71M

2025Q1

463

58.20M

104.56%

-2.86M

2024Q4

457

54.99M

99.23%

-4.48M

2024Q3

452

53.78M

101.72%

-11.43M

2024Q2

424

54.82M

104.96%

-13.18M

2024Q1

450

55.58M

107.13%

-14.92M

2023Q4

462

54.27M

100.29%

-16.52M

2023Q3

493

55.98M

103.34%

-21.97M

2023Q2

517

57.57M

107.02%

-21.82M

2023Q1

532

58.67M

109.28%

-16.17M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

4.82M

8.66%

-25.66K

-0.53%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

4.21M

7.56%

-77.53K

-1.81%

Mar 31, 2025

State Street Global Advisors (US)

2.48M

4.46%

-174.50K

-6.56%

Mar 31, 2025

Baron Capital Management, Inc.

2.19M

3.93%

-17.29K

-0.78%

Mar 31, 2025

Gagnon Securities LLC

1.42M

2.55%

-9.51K

-0.66%

Mar 31, 2025

ARK Investment Management LLC

2.35M

4.22%

-61.72K

-2.56%

Mar 31, 2025

Invesco Advisers, Inc.

1.88M

3.39%

+1.12M

+147.36%

Mar 31, 2025

Ophir Asset Management Pty Ltd

1.62M

2.91%

+1.62M

Mar 31, 2025

Hood River Capital Management LLC

1.58M

2.84%

+1.58M

Mar 31, 2025

Fred Alger Management, LLC

1.43M

2.58%

-179.38K

-11.11%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

ARK Genomic Revolution ETF

3.93%

Invesco Biotechnology & Genome ETF

2.95%

ROBO Global Healthcare Technology & Innovation ETF

1.43%

Invesco Dorsey Wright Healthcare Momentum ETF

1.43%

Global X Genomics & Biotechnology ETF

1.3%

Franklin Genomic Advancements ETF

0.52%

Main Thematic Innovation ETF

0.42%

SPDR S&P Biotech ETF

0.35%

First Trust Small Cap Growth AlphaDEX Fund

0.24%

VictoryShares US Small Mid Cap Value Momentum ETF

0.24%

ARK Genomic Revolution ETF

佔比3.93%

Invesco Biotechnology & Genome ETF

佔比2.95%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.43%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比1.43%

Global X Genomics & Biotechnology ETF

佔比1.3%

Franklin Genomic Advancements ETF

佔比0.52%

Main Thematic Innovation ETF

佔比0.42%

SPDR S&P Biotech ETF

佔比0.35%

First Trust Small Cap Growth AlphaDEX Fund

佔比0.24%

VictoryShares US Small Mid Cap Value Momentum ETF

佔比0.24%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

KeyAI

